Clinical Trials
10
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic
- Conditions
- Hepatitis C, ChronicOpiate DependenceHepatitis C
- Interventions
- First Posted Date
- 2017-08-01
- Last Posted Date
- 2021-05-13
- Lead Sponsor
- Community Research Initiative of New England
- Target Recruit Count
- 11
- Registration Number
- NCT03235154
- Locations
- 🇺🇸
Cambridge Health Alliance Outpatient Addiction Services, Somerville, Massachusetts, United States
A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
- Conditions
- HIV InfectionsAcquired Immune Deficiency Syndrome
- Interventions
- First Posted Date
- 2010-08-02
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- Community Research Initiative of New England
- Registration Number
- NCT01173510
BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.
- Conditions
- HIV
- Interventions
- Drug: atazanavir/raltegravirDrug: atazanavir/tenofovir/emtricitabine
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Community Research Initiative of New England
- Target Recruit Count
- 43
- Registration Number
- NCT00931801
- Locations
- 🇺🇸
Spectrum Medical Group, Phoenix, Arizona, United States
🇺🇸AIDS Healthcare Foundation, Los Angeles, California, United States
🇺🇸Denver Public Health, Denver, Colorado, United States
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
- Conditions
- HIV Infections
- Interventions
- Drug: DRV/rDrug: ATV/r
- First Posted Date
- 2008-09-22
- Last Posted Date
- 2017-08-21
- Lead Sponsor
- Community Research Initiative of New England
- Target Recruit Count
- 49
- Registration Number
- NCT00756730
- Locations
- 🇺🇸
Spectrum Medical Group, Phoenix, Arizona, United States
🇺🇸AIDS Healthcare Foundation, Los Angeles, California, United States
🇺🇸Orlando Immunology Center, Orlando, Florida, United States
BRAVO: Background Regimen of Raltegravir on Virologic Outcome
- First Posted Date
- 2008-09-12
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Community Research Initiative of New England
- Target Recruit Count
- 442
- Registration Number
- NCT00751530
- Locations
- 🇺🇸
Light Source Medical, Los Angeles, California, United States
🇺🇸AIDS Healthcare Foundation, Los Angeles, California, United States
🇺🇸Synergy Hematology and Oncology, Los Angeles, California, United States
- Prev
- 1
- 2
- Next